XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Sales, net $ 43,596,926 $ 94,818,938 $ 188,382,454
Cost of sales:      
Total cost of sales 34,489,115 66,565,655 93,029,933
Gross profit 9,107,811 28,253,283 95,352,521
Operating expenses:      
Sales and marketing 5,706,483 4,544,052 4,477,651
Research and development 581,172 525,727 901,381
General and administrative 14,308,365 24,036,480 17,378,301
Total operating expenses 20,596,020 29,106,259 22,757,333
Income (loss) from operations (11,488,209) (852,976) 72,595,188
Gain on forgiveness of PPP loan     1,377,652
Other income - TIA 6,223,891 3,832,747 425,158
Unrealized gain (loss) on debt and equity securities (10,521,166) 2,343,359 513,529
Gain on sale of equity securities 5,574,792 (327,926)  
Interest and other income 1,446,661 9,948 266,467
Interest expense (152,166) (170,651) (227,183)
Income before income taxes (8,916,197) 5,162,427 74,950,811
Provision for income taxes expense (benefit) (1,905,161) 83,870 18,886,570
Net income (loss) (7,011,036) 5,078,557 56,064,241
Preferred Stock dividend requirements (231,946) (232,444) (241,703)
Net income (loss) applicable to common shareholders $ (7,242,982) $ 4,846,113 $ 55,822,538
Basic earnings (loss) per share $ (0.24) $ 0.15 $ 1.65
Diluted earnings (loss) per share $ (0.24) $ 0.15 $ 1.63
Weighted average common shares outstanding:      
Basic (in shares) 29,937,159 32,896,348 33,870,819
Diluted (in shares) 29,937,159 32,961,945 34,244,699
Costs of manufactured product      
Cost of sales:      
Total cost of sales $ 30,894,985 $ 60,628,548 $ 81,711,840
Royalty expense to shareholder      
Cost of sales:      
Total cost of sales $ 3,594,130 $ 5,937,107 $ 11,318,093